Clinical

Pandemic affecting rates of type 1 diabetes in children
Multiple studies show big jumps in diabetic ketoacidosis.
Financial planning strategies and tools to simplify your business
Do you have the right financial structure and tools in place to maximize profit and time savings opportunities? You will benefit from a Financial Health Check-up for Physicians and Medical Practitioners. Click to learn how to improve your business performance, and to register for a webinar and Q&A on May 26 with KWB Chartered Professional Accountants and Advisors.
Sponsored

Prescribing or dispensing Paxlovid? Here's what you need to know

Pharmacists prescribing Paxlovid need to navigate public misunderstandings about its effectiveness, a long list of drug interactions, and high-risk populations not being aware of it as an option.
ctDNA test in question for detecting colorectal cancer recurrence

Study finds the liquid biopsy is no more reliable than imaging surveillance.
POP QUIZ: Nutraceuticals and phytoceuticals for psychiatric disorders

Based on the WFSBP/CANMAT 2022 guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals, which of the following statements is FALSE?
How to diagnose and treat long COVID cardiac symptoms

What to do when patients come in with cardiac symptoms following COVID infection.
Zeposia approved for treatment of moderately to severely active ulcerative colitis

Intended for adults with an inadequate response, loss of response or intolerance to conventional therapy or a biologic agent.
Health Canada issues treatment failure warning for COVID-19 monoclonal antibody therapy

The warning came last week for sotrovimab and noted it's 'unlikely' to maintain efficacy against the BA.2 subvariant of Omicron.
QUIZ: Test your knowledge of preventing fractures in postmenopausal patients

How much do you know about evaluating risk and preventing fractures in postmenopausal patients?
Montreal study shows effectiveness of fluvoxamine against COVID-19

A new study from the Research Institute of the McGill University Health Centre (RI-MUHC) confirms the benefits of fluvoxamine in preventing the risk of hospitalization following a COVID-19 infection.